For investors

You are buying more than the numbers

Underperforming technology, hidden cost, and integration that quietly loses the value the model assumed. Lens gives investment teams one place to test what they are buying, then hold the portfolio to what was promised.

The problem

Risk arrives late and leaves no trace

Diligence starts once the timetable is fixed. Findings live in a report that is read once. By the time a portfolio company underperforms, nobody can point to the moment the risk was first visible — or whether anyone acted on it.

Buying risk you cannot see

Architecture, key-person concentration and technical debt rarely surface in the information memorandum. They surface in year two, priced into the exit.

Technology that cannot be valued

AI has made capability harder to assess. Differentiation has to be tested — proprietary data, workflow depth, model dependency, reproducibility — not accepted from a slide.

Integration that loses value

The synergies underwritten at signing depend on integration work nobody has yet owned. The plan is usually built after the findings have gone cold.

Cost that appears afterwards

Remediation, licensing, hiring and platform rebuild are ordinary post-close discoveries. Ordinary, and almost always excluded from the model.

Outside-in first

Know more before the data room

A great deal can be established externally: product, hiring signals, security posture, architecture, commercial claims. Early assessment shapes the questions you ask rather than the answers you are handed.

  1. 01

    Screen before you commit

    A low-risk early read on product and cyber exposure, before the fee clock and the exclusivity window start.

  2. 02

    Form a testable hypothesis

    Turn the investment thesis into a small number of decisions the diligence has to inform, and the evidence each one requires.

  3. 03

    Take it into full diligence

    The outside-in view becomes the scope. Nothing is re-derived, and the request list opens with the questions that already matter.

Lens target assessment view showing scored evaluation across assessment areas
Target assessment — scored, sourced, comparable

Across the portfolio

One view of every holding, on the same scale

Because every engagement runs the same workstream taxonomy and index scoring, holdings become comparable. You can see where a portfolio company sits, what changed this quarter and what the evidence behind that movement was.

Lens portfolio board showing deals across pipeline stages
Portfolio board — pipeline and live holdings
Lens Pulse daily narrative brief across projects
Pulse — a daily brief for partners

Defensible by design

Every conclusion traces back to a source

Lens answers questions from your own dataroom, interviews and journal entries, and cites what it used. That matters at investment committee, it matters at exit, and it matters when someone asks in eighteen months why a decision was made.

Evidence trail

Findings link to the documents, requests and interviews behind them. The audit trail is a by-product of the work, not a separate exercise.

IC-ready output

Index scores and workstream summaries are drawn from the same evidence the team worked from — no re-keying into a deck.

Institutional memory

What the fund learns on one deal is available on the next, rather than leaving with the adviser or the analyst.

See Lens against a live or recent deal

Thirty minutes on a structure that looks like yours — outside-in through diligence into value creation.

Book a demo